Design considerations and clinical experience of a novel thin-walled high-performance bioresorbable coronary scaffold

Sponsored by Amaranth Medical

Chairpersons: A. Colombo, G.W. Stone

Learning Objectives

  • To understand the design considerations and performance characteristics of polymeric drug-eluting bioresorbable coronary scaffolds
  • To compare the performance of current-generation BRS to metallic DES
  • To learn about the latest generations of poly-L-lactide-based BRS with wall thicknesses approaching that of metallic BRS

Presentations available when logged in:

  • Session objectives
  • The future of BRS technologies: technical lessons learned from the Absorb BVS programme
  • The Amaranth Medical BRS: development of a thin-walled novel poly-L-lactide-based polymeric BRS
  • Clinical update: from FORTITUDE 150 to APTITUDE 115
  • Technology pipeline: the MAGNITUDE sub-100 BRS programme